To evaluate the effect of autologous human serum (AHS) versus pooled human serum (PHS) versus foetal bovine serum (FBS) for growth of articular chondrocytes and formation of chondrocytefibrin constructs. Methods. Experiments with monolayer culture expansion of human articular chondrocytes were performed using basic culture media supplemented with 10% AHS, PHS, or FBS. Growth kinetics and specific phenotypic expression of the serially expanded chondrocytes were evaluated. Largescale culture expansion was used to obtain about 30 million cells to form chondrocyte-fibrin constructs. All constructs were implanted subcutaneously at the dorsum part of athymic nude mice for 8 weeks. The in vivo constructs were evaluated using histological and gene expression studies. Results. The morphology of primary cultured chondrocytes (P0) was polygonal and became more elongated and larger after serial passages (P1, P2, and P3). This was comparable for AHS, PHS, and FBS. Total cell yields accumulated for AHS (28 million) and Journal of Orthopaedic Surgery 2008;16(2):220-9 PHS (41 million) were significantly higher than those for FBS (4 million). After 8 weeks of implantation, in vivo chondrocyte-fibrin constructs demonstrated a glistening white and firm texture, comparable to normal hyaline cartilage. All constructs exhibited histo-architectural characteristics of well-distributed cartilage-isolated cells embedded within basophilic ground substance. Presence of accumulated proteoglycans cartilage-rich matrix was indicated by positive orange-red Safranin O staining. During monolayer culture expansion, collagen type II gene expression was down-regulated, while collagen type I gene expression was up-regulated. Collagen type II-the specific chondrogenesis marker-was reexpressed in the in vivo chondrocyte-fibrin construct. Conclusion. AHS and PHS are better than FBS for in vitro cultivation of human articular chondrocytes.
INTRODUCTION
Tissue engineering and regenerative medicine technology is a viable method for restoration of cartilage defects following articular cartilage injury. Translating this into a clinical application necessitates characterisation of human chondrocytes to determine their suitability for tissue engineering. Increased cell growth rate with shorter culture periods is beneficial when preparing cartilage implants for clinical use. As only limited amounts of autologous cartilage can be harvested without causing donor-site morbidity, monolayer culture expansion is essential to generate sufficient chondrocytes to form in vitro constructs of an appropriate size.
Culture medium plays an important role in chondrocyte growth 1 and provides phenotypic stability of tissue-engineered cartilage constructs. Various types of basal culture media supplemented with animal serum have been widely used to provide basic nutrients for human chondrocytes. However, animal serum is not suitable for regeneration of clinical transplants as it risks transmission of viraland prion-related diseases.
Reconstruction of autologous tissue-engineered cartilage using autologous human serum (AHS) may reduce risks of disease transmission and immune rejection. 2, 3 However, blood withdrawal is critical for ill or hypovolaemic patients. Therefore, pooled human serum (PHS) may be a substitute for growth-promoting agents in human chondrocyte cultures. 4 First described in 1994, 5 autologous chondrocyte implantation (ACI) has been widely used to treat symptomatic joint surface defects. [6] [7] [8] [9] ACI uses periosteum to contain the chondrocytes and requires open arthrotomy for implantation. In vitro reconstruction of biological 3-dimensional cartilage implants does not require invasive surgery and facilitates arthroscopic implantation. It is nevertheless a challenge to reconstruct such implants with normal cartilage properties to provide natural repair and integrate with the adjacent tissues.
We performed several in vitro studies to form chondrocyte-fibrin constructs using different sources, 10 such as human articular chondrocytes, [11] [12] [13] nasal septum chondrocytes, [14] [15] [16] and auricular chondrocytes. [17] [18] [19] Good quality in vivo constructs comparable to native hyaline cartilage were developed. 10, 12, 14, 20 The constructs were implanted into full-thickness osteochondral punch-hole defects in the femoral condyles of sheep; good quality cartilagelike tissue was restored, with excellent chondral and osseous integration to the adjacent tissues. [21] [22] [23] We aimed to investigate the potential of AHS and PHS to substitute foetal bovine serum (FBS) supplementation in basic culture medium for in vitro growth of human articular chondrocytes. We also aimed to report the serial changes and morphological appearance of the monolayer cultured chondrocytes, and evaluate the chondrocyte-fibrin constructs.
MATERIALS AND METHODS

Cartilage harvest, chondrocyte isolation, and monolayer culture expansion
This study was approved by the ethics committee of our university. Informed consent was obtained from all patients. Cartilage was obtained as an excessive tissue from 15 patients aged 13 to 77 (mean, 45; standard error [SE], 5) years after joint surgery. Each specimen was placed in normal saline and transported to the tissue engineering laboratory and processed within 6 to 12 hours.
Each specimen was washed with phosphate buffered saline (PBS) containing 100 μ/ml penicillin and streptomycin each, and then minced into small fragments and digested with 0.6% collagenase type II in an orbital incubator (at 37ºC for 6 hours) for isolation of chondrocytes. The resulting cell suspension was centrifuged at 6000 rpm for 5 minutes at 37ºC, and the cell pellet washed with PBS to remove the remaining enzyme. After centrifugation, cell pellets were resuspended in PBS for total cell counting using a haemacytometer. Cell viability was determined using the trypan blue dye exclusion test. Harvested chondrocytes were then seeded in 6 well-plates; the initial seeding entailed 5000 cells/cm 2 .
Samples were assigned to 3 groups. Chondrocytes were cultured in the mixture of equal volume of F12: DMEM (1:1) supplemented with 10% AHS, PHS, or FBS plus antibiotics and an antimycotic, 200 mM Lglutamine, 50 µg/ml of ascorbic acid, and 15 mM HEPES buffer 1M. All cultures were maintained in a 5% CO 2 incubator at 37ºC, with the medium changed 2 to 3 times per week. Once confluent, the primary cultured cells (P0) were trypsinised using 0.05% Trypsin-EDTA. Chondrocytes were subsequently cultured for 3 more passages (P1, P2, and P3) in the same condition as P0. Total cell counts and cell viability were recorded for every passage.
The morphological features of the chondrocytes were examined daily using a phase contrast inverted light microscope. The growth rate (cells/day/cm 2 ) and total number of cell doubling was calculated at every passage. The non-parametric Kruskal-Wallis test was used to compare the medians for the 3 groups as the data were not normally distributed. Differences were considered statistically significant when the p value was <0.05.
Formation and implantation of chondrocyte-fibrin constructs
Human articular chondrocytes were cultured in 175 cm 2 culture flasks at a density of 5000 cells/cm 2 . After the cells reached confluency, they were harvested by trypsinisation, and then measured for total cell count and viability. About 30x10 6 cells/ml were incorporated with fresh human fibrin. 24 The chondrocyte-fibrin admixture was polymerised with 250 mM calcium chloride (CaCl 2 ) to form a gel-like construct. Fibrin was used as a temporary scaffold material to preserve cells in a 3-dimensional environment and to mimic the conditions in actual native tissue before the cells could produce their own matrices. Fibrin was derived from the patient's own plasma extracted from whole blood by 4800 rpm centrifugation for 5 minutes at 37ºC. The chondrocyte-fibrin constructs were maintained for 3 weeks in vitro prior to subcutaneous implantation on the dorsum of athymic nude mice. After 8 weeks, the in vivo chondrocyte-fibrin constructs were dissected, weighed, and processed for histological and gene expression studies. Fibrin blanks (polymerised fibrin without cells) were used as controls.
Histological and immunohistochemistry analyses of in vivo chondrocyte-fibrin constructs
Each dissected construct was assessed grossly and palpated with forceps for mechanical rigidity by an observer blinded to the protocol. Specimens were then prepared for histological analyses. After fixation with 10% formalin for 24 hours, the specimens were embedded in paraffin block and sectioned with a microtome. Sections were stained with haematoxylin and eosin to assess cells and tissue morphology or Safranin O to identify the presence of accumulated proteoglycans.
For immunohistochemistry, all sections were deparaffinised prior to immunolocalisation of collagen types I and II, according to the immunohistochemical staining protocol of the manufacturer. All sections were pre-treated with proteinase K at 37ºC for one hour and washed 3 times with Tris-buffered saline (TBS). All sections were then treated with peroxidase block at 37ºC for 10 minutes, prior to incubation with the monoclonal antibody. Monoclonal antibody mouse anti-human collagen types I and II were diluted with antibody DILUENT (1:200) and applied to the sections for 40 minutes at 37ºC. After washing with TBS, the sections were applied with peroxidaselabelled polymer conjugated to goat anti-mouse Ig (horseradish peroxidase) for 40 minutes at 37ºC. The signal was finally visualised as a brownish precipitate using the freshly prepared peroxidase substrate 3,3'-diaminobenzidine. Sections were counterstained with haematoxylin and mounted in glycerol gel.
Total ribonucleic acid isolation and semi-quantitative one-step reverse transcriptase polymerase chain reaction
Total ribonucleic acid (RNA) was extracted from the respective 1x10 5 fresh isolated chondrocytes, serial expanded chondrocytes at P0, P1, P2, and P3 and isolated chondrocytes from in vivo chondrocyte-fibrin constructs using TRI reagent to build up a profile of the changes in gene expression. The extraction procedure was performed according to the manufacturer's instructions. A cell lysate was centrifuged at 12 000 rpm at 4ºC for 5 minutes. The supernatant was then transferred into a 15 ml centrifugal tube. Chloroform was added into the tube containing supernatant and was then shaken vigorously for 10 seconds. After 10 minutes of incubation at room temperature, the mixture was centrifuged for 15 minutes at 4ºC at 12 000 rpm and formed 3 separated layers consisting of RNA, protein, and deoxyribonucleic acid (DNA). The clear liquid phase consisting of RNA was transferred into an empty 15 ml centrifugal tube. 5 µl of polyacryl carrier was used to precipitate the total RNA and was then washed with 75% ethanol and air-dried. Yield and purity of the extracted RNA was determined spectrophotometrically.
The expression of collagen type II (forward: 5'-ctggcaaagatggtgagacaggtg-3' and reverse: 5'gaccatcagtgccaggagtgc-3') and type I (forward: 5'-aaggcttcaaggtccccctggtg-3' and reverse: 5'cagcaccagtagcaccatcatttc-3') were evaluated using the semi-quantitative one-step reverse transcriptase polymerase chain reaction (RT-PCR) technique with human β-actin gene (forward: 5'-ccggcttcgcgggcgacg-3' and reverse: 5'-tcccggccagccaggtcc-3') as control. The specific sense (forward) and anti-sense (reverse) primers used in the reaction were designed and made at the US National Institutes of Health GenBank database.
The one-step RT-PCR reaction mix was prepared according to the manufacturer's instructions with slight modification; 25 µl instead of 50 µl reaction volume was used to increase the sensitivity of the test. Each reaction consisted of 100 ng of total RNA and 10 pmol of each sense and anti-sense primers. The semi-quantitative one-step RT-PCR protocol was performed with a reaction profile of cDNA synthesis for 30 minutes at 50ºC, pre-denaturation for 2 minutes at 94ºC, PCR amplification for 38 cycles with 30 seconds at 94ºC, 30 seconds at 60ºC, and 30 seconds at 72ºC. This series of cycles was followed by a finale extension of 72ºC for 2 minutes. Subsequently, 6 µl of the amplified PCR products were separated using 1.5% agarose gel electrophoresis, stained with ethidium bromide, and visualised by ultraviolet transillumination.
RESULTS
Cartilage harvest, chondrocytes isolation, and monolayer cultivation
The mean weight of human articular cartilage specimens obtained was 285 (SE, 63) mg ( Table 1) . The mean initial cell yield was 3.78x10 5 (SE, 1.39x10 5 ) cells per mg after a 12-hour digestion in 0.6% collagenase type II. There was no significant correlation between initial cell yield, sample weight, donor age, and sex ( Table 2) .
Chondrocytes grown in basic culture medium supplemented with 10% AHS, PHS, or FBS demonstrated comparable morphological appearance during monolayer expansion ( Fig.  1 ). Daily macroscopic observation demonstrated that chondrocytes multiplied faster in AHS and PHS than FBS supplementation. Cell proliferation gradually decreased after extensive monolayer culture expansion, resulting in longer time to reach confluency. Chondrocytes at P0 reached confluence within 2 to 3 weeks and appeared polygonal; the morphology changed to more fibroblast-like and more elongated and larger at P1, P2 and P3. At P1 and P2 respectively, chondrocytes grew significantly faster in both AHS (3786 and 1246 cells/ day/cm 2 ) and PHS (3720 and 2530 cells/day/cm 2 ) than in FBS (740 and 372 cells/day/cm 2 ) [p=0.04 and p=0.008, Table 3 ]. At P2, chondrocytes demonstrated a significantly shorter doubling time in both AHS (5.8 days) and PHS (3.3 days) than in FBS (14 days) [p=0.034, Table 3 ]. The total number of cell doubling (indicating the magnitude of chondrocyte expansion in culture) was 9.15 in AHS, 9.67 in PHS, and 6.14 in FBS (p=0.008, Table 3 ). The total cell yield that accumulated at the end of each experiment was significantly higher in AHS (28.3x10 6 cells) and PHS (40.8x10 6 cells) than in FBS (3.53x10 6 cells) [p=0.008, Table 3 ]. There was no significant difference between AHS and PHS with respect to growth kinetics assessments (p>0.28). Cell viability was >90% at every passage, with no significant difference between AHS, PHS, and FBS (p=0.5).
In vitro chondrocyte-fibrin construct formation
Chondrocyte-fibrin constructs were stabilised for 3 weeks in vitro in their culture media prior to subcutaneous implantation into athymic nude mice. After 3 weeks of incubation, all in vitro chondrocytefibrin constructs demonstrated stable forms of gellike implants (Fig. 2a) . Histologically, the constructs displayed closely packed homogenous cells distributed within an underdeveloped matrix network. There were no signs of newly developed cartilage-isolated cells in the lacunae space. The specific cartilage proteoglycan rich matrix was not present after Safranin O staining. The immature constructs demonstrated weak expression of collagen type II localised to and surrounding the underdeveloped pericellular matrix. Collagen type I expression was seen throughout the extracellular matrix of the construct.
Macroscopic observation, histological evaluation, and immunohistochemistry analysis of in vivo chondrocyte-fibrin constructs
After 8 weeks of implantation, the dissected in vivo chondrocyte-fibrin constructs exhibited cartilagelike, gross, white, glistening, firm characteristics comparable to normal hyaline cartilage (Fig. 2b) . The constructs exhibited histo-architectural characteristics of well-distributed cartilage-isolated cells located in lacunae spaces. These cells were embedded within the basophilic ground substance of a newly developed cartilage-like construct (Fig. 3a) . Under positive Safranin O staining, the constructs were avascular and homogenous, displaying histochemical properties consistent with the presence of an accumulated proteoglycan rich matrix (Fig. 3b ). The constructs demonstrated strong immunoreactivity of collagen type II at the pericellular matrix of cartilage-isolated cells (Fig. 3c) . Notably, this cartilage-specific marker was distributed throughout the extracellular matrix of the newly developed cartilage-like construct, indicating the presence of a mature cartilage phenotype. Collagen type I was deposited around the pericellular matrix of the launae (Fig. 3d ). 
Chondrocytes
Total ribonucleic acid isolation and semi-quantitative one-step reverse transcriptase polymerase chain reaction
This chimerical study offered an opportunity to selectively monitor gene expression of human tissue within mice tissue by the semi-quantitative one step RT-PCR analysis using human-specific primers. Chondrocytes cultured in AHS, PHS, and FBS revealed similar expression patterns of collagen types I and II genes in every passage (P0, P1, P2, P3). One-step RT-PCR analysis demonstrated that collagen type II gene (the cartilage-specific marker) was strongly expressed in the freshly isolated chondrocytes, while collagen type I gene expression was not detected. During monolayer culture expansion, collagen type II gene was strongly expressed in the primary cultured chondrocytes (P0). Its expression declined at P1 and finally at P2 and P3 no expression of the collagen type II gene was detected. On the contrary, the expression of collagen type I (a marker of the loss of mature chondrocytic phenotype) was detected as soon as the P0 stage began. Collagen type I was steadily expressed throughout P1, P2, and P3 culture (Fig. 4) . In vitro constructs comprising serially passaged chondrocytes demonstrated similar collagen types I and II gene expression patterns to those of monolayer cultured chondrocytes. Loss of the mature chondrocytic phenotype by the serially expanded chondrocytes gives a clue to the inability of in vitro chondrocyte-fibrin constructs to spontaneously preserve phenotypically stable mature cartilage. The collagen type II gene was re-expressed in the newly developed in vivo chondrocyte-fibrin constructs, confirming the presence of a specific cartilage phenotype. Beta-actin gene was constantly expressed in every passage, validating one-step RT-PCR analysis.
DISCUSSION
Tissue engineering for cartilage repair has attracted much attention in the orthopaedic field. 25, 26 We compared the potential of AHS and PHS as an FBS substitute in culture medium in order to promote human articular chondrocyte growth.
The amount of harvested tissue is an important measure for assessing tissue suitability. In this study, the mass of recovered cartilage of 297 (SD, 64) mg was smaller than the amounts recommended for cartilage biopsy of ACI (350 to 500 mg), 5-7 but we managed to obtain reasonable optimum starting materials. The cartilage samples determined the amount of the primary cells that could be isolated for in vitro cultivation. It is important to obtain sufficient numbers of primary cells to avoid extensive monolayer culture expansion. In this study, monolayer cultured chondrocytes proliferated more rapidly (having shorter doubling times) in AHS and PHS than in FBS supplementation. It would take approximately 3 to 4 weeks to form a 1 cm 3 chondrocyte-fibrin construct, given a mean initial cell yield of approximately 3.78x10 5 cells and a doubling time of 5.78 days in AHS and 3.28 days in PHS. Reduction of the population doubling time reduces the time gap between the tissue-harvesting procedure and re-implantation of the constructs into the patient.
The morphology of serially expanded chondrocytes changed from polygonal to becoming more elongated and larger. At later passages, chondrocytes seem to adopt many of the phenotypic traits of fibroblast-like cell, and synthesise more of collagen type I rather than type II. This phenomenon has been reported for human nasal septum chondrocytes, 22 auricular chondrocytes, 17 and articular chondrocytes, 10, 12 and was likely due to modification of the cytoskeleton, 27 consistent with a previous study using nasal septum chondrocytes. 28 The chondrocyte-specific gene (collagen type II) was down-regulated with time, while the collagen type I gene was pre-dominantly expressed at later passages. [2] [3] [4] Chondrocytes cultured in AHS, PHS, and FBS demonstrated no variation of collagen types I and II gene expression patterns. In a single cell approach studying the influences of growth factor exposure, seeding time, and cartilage zone on biosynthetic and catabolic gene expression, collagen type I gene expression was not detected in any cultured cell. 29 Chondrocytes require a 3-dimensional matrix to maintain phenotypical stability. 30 To reinforce expression of the cartilage specific marker, chondrocyte-fibrin constructs were maintained for 3 weeks in vitro prior to subcutaneous implantation. Total RNA isolated from in vitro chondrocyte-fibrin constructs revealed similar gene expression patterns to that of monolayer cultured cells. The collagen type II gene expression was detectable only in the in vitro constructs comprising harvested cells from the earlier passages (i.e. P0 and P1 stages). At these stages, cultured cells had not yet undergone extensive culture expansion and modification. After extended culture expansion, chondrocytes lose their specific phenotype thereby the ability to produce cartilage-specific matrix products. 10, 12, 14 In vitro cartilages comprising chondrocyte-alginate hybrid constructs did not express the cartilage specific marker (collagen type II) during in vitro incubation. 31 Constructs comprising umbilical cord blood mesenchymal progenitor cell displayed no evidence of chondrogenic differentiation after 4 weeks in the bioreactor, but chondrogenic differentiation and characteristics of hyaline cartilage were displayed after 12 weeks. 32 Chondrocyte-fibrin constructs were subcutaneously implanted at the dorsum part of athymic nude mice. In vivo chondrocyte-fibrin constructs were white, smooth, glistening, and firm, comparable to normal hyaline cartilage, 13, 14 and demonstrated normal histo-architectural characteristics and accumulated proteoglycan cartilage rich matrix. 10, 11 The presence of the cartilage-specific marker (collagen type II) in the in vivo constructs indicated presence of the newly synthesised cartilagespecific extracellular matrix molecule. 12 Collagen type I was co-expressed in the newly developed in vivo constructs, suggesting that the phenotypically immature cartilage was progressing towards maturity. 33, 34 Chondrocyte-synthesised collagen type I accumulated the protein in the matrix during articular cartilage development. In this study, in vivo constructs formed by serially expanded chondrocytes from later passages (P1, P2, and P3) revealed equivalent characteristics to the in vivo constructs derived from the primary cultured cells (P0). 13, 31 Further assessment by immunohistochemical localisation using specific human monoclonal antibodies demonstrated the ability of in vivo constructs to produce specific cartilage-like matrix. 11 This was proved by the presence of accumulated pericellular matrix with lacunae composed of newly synthesised collagen type II. We successfully engineered 3-dimensional in vitro chondrocyte-fibrin constructs using serially expanded human articular chondrocytes in basic culture media supplemented with AHS, PHS, or FBS.
In this study, although the age range of the donors was wide (13-77 years), the articular cartilage samples remained viable across all age-groups. No significant correlation was noted between donor age and chondrocytic capacity. This implies that tissue engineering of human articular chondrocytes is possible for a broad collection of patient.
CONCLUSION
Supplementation of 10% AHS or PHS is superior to FBS for in vitro monolayer culture expansion and for in vivo chondrocyte-fibrin construct formation. Regenerated 3-dimensional cartilage implants supplemented with AHS or PHS may be useful for future clinical applications.
